In current endocrine signaling bench science, the fastest growing challenge is not simply measuring a response, but comparing responses across receptor families, across timepoints, and across assay ...
Collaborative research led by ARG's Medical Affairs Team and Scientific Advisory Board reinforces the company's commitment to thyroid category leadership The research presents an integrative framework ...
Peptide hormones and bile acids shaping immune tolerance of the liver: implications and applications
The exceptional immune tolerance of the liver is, in part, mediated by entero-pancreatic endocrine factors that enter the portal vein at elevated levels. These endocrine factors signal via cAMP, ...
CDK 4/6 inhibitors (CDK4/6i) remain part of the standard first-line treatment for patients with hormone receptor–positive metastatic breast cancer, offering demonstrable improvements in both ...
Association of circulating T lymphocytes and their functional states with pathologic complete response (pCR) in breast cancer (BC). A prospective Italian study. This is an ASCO Meeting Abstract from ...
In some cases, HR-positive/HER2-negative breast cancers may over time become resistant to endocrine therapy. This can occur through mutations in the estrogen receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results